Literature DB >> 9665296

Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto.

R Kaiser1, S Rauer.   

Abstract

The intrathecal synthesis of borrelial-specific IgM- and IgG-antibodies was studied in 67 patients with neuroborreliosis and in 14 patients with neurosyphilis (controls). Antibody concentrations in serum and in the cerebrospinal fluid were determined by an enzyme immunoassay (EIA) using, as antigens, a sonicate of Borrelia burgdorferi, the recombinant 14 kDa flagellin fragment, the outer surface protein C (22 kDa), and the high molecular mass protein p83 (83 kDa). In the sonicate EIA, IgG- and/or IgM-antibodies to Borrelia burgdorferi in serum were detected in all patients with neuroborreliosis and in 71% of patients with neurosyphilis. Intrathecal synthesis of borrelial-specific IgG- and/or IgM-antibodies was demonstrated in 82% of patients with neuroborreliosis and in 71% of patients with neurosyphilis. Immunoglobulin G- and/or IgM-antibodies in serum against any of the recombinant antigens were detected in 92% of patients with neuroborreliosis and in none of those with neurosyphilis. Intrathecal synthesis of IgG- and/or IgM-antibodies to individual recombinant antigens was demonstrated in 67% of patients with neuroborreliosis and in none of those with neurosyphilis. The sensitivity of the recombinant antigens in serum was almost equal to that of the sonicate EIA, whereas the recombinant antigens were clearly less sensitive in the estimation of the intrathecal specific immune response. It was concluded that in suspected cases of neuroborreliosis, the estimation of high specific antibodies in the recombinant EIA will be helpful in confirming the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665296     DOI: 10.1007/bf01691111

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  40 in total

1.  Evidence that Borrelia burgdorferi immunodominant proteins p100, p94 and p83 are identical.

Authors:  H J Ditton; M Neuss; L Zöller
Journal:  FEMS Microbiol Lett       Date:  1992-07-15       Impact factor: 2.742

2.  Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin.

Authors:  E Fikrig; E D Huguenel; R Berland; D W Rahn; J A Hardin; R A Flavell
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

Review 3.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Intrathecal immune response in neuroborreliosis: importance of cross-reactive antibodies.

Authors:  R Kaiser
Journal:  Zentralbl Bakteriol       Date:  1995-04

5.  Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.

Authors:  J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

6.  The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen.

Authors:  B J Luft; S Mudri; W Jiang; R J Dattwyler; P D Gorevic; T Fischer; P Munoz; J J Dunn; W H Schubach
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.

Authors:  B Wilske; V Fingerle; P Herzer; A Hofmann; G Lehnert; H Peters; H W Pfister; V Preac-Mursic; E Soutschek; K Weber
Journal:  Med Microbiol Immunol       Date:  1993-11       Impact factor: 3.402

8.  Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

Authors:  S Hammers-Berggren; K Hansen; A M Lebech; M Karlsson
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

9.  Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis.

Authors:  H Tumani; G Nölker; H Reiber
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

Review 10.  Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E L Logigian; M F Finkel; R A Pearl
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  12 in total

1.  Humoral immune responses in patients with Lyme neuroborreliosis.

Authors:  Tjasa Cerar; Katarina Ogrinc; Franc Strle; Eva Ruzić-Sabljić
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

2.  Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis.

Authors:  Gerold Stanek; Lara Lusa; Katarina Ogrinc; Mateusz Markowicz; Franc Strle
Journal:  Med Microbiol Immunol       Date:  2013-12-23       Impact factor: 3.402

3.  [Neurosyphilis and neuroborreliosis. Retrospective evaluation of 22 cases].

Authors:  R Blatz; H-J Kühn; W Hermann; M Rytter; A C Rodloff
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

Review 4.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

5.  CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Authors:  Unn Ljøstad; Ase Mygland
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

6.  Preferential presence of decorin-binding protein B (BBA25) and BBA50 antibodies in cerebrospinal fluid of patients with neurologic Lyme disease.

Authors:  Erol Fikrig; Patricia K Coyle; Steven E Schutzer; Manchuan Chen; Zhidian Deng; Richard A Flavell
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 7.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

8.  CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Authors:  U Ljøstad; Å Mygland
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

9.  Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.

Authors:  T Cerar; K Ogrinc; S Lotric-Furlan; J Kobal; S Levicnik-Stezinar; F Strle; E Ruzić-Sabljic
Journal:  Clin Vaccine Immunol       Date:  2013-08-14

10.  Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.

Authors:  Tamara van Gorkom; Willem Voet; Gijs H J van Arkel; Michiel Heron; B J A Hoeve-Bakker; Daan W Notermans; Steven F T Thijsen; Kristin Kremer
Journal:  Microbiol Spectr       Date:  2022-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.